Skip to main content
Pharnext logo

Pharnext — Investor Relations & Filings

Ticker · ALPHA ISIN · FR0011191287 LEI · 969500KJGF9ZUYXSMJ27 Euronext Growth Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2018-04-26 Board/Management Inform…
Country FR France
Listing Euronext Growth ALPHA

About Pharnext

https://pharnext.com/

Pharnext is an advanced clinical-stage biopharmaceutical company that develops novel therapeutics for neurodegenerative diseases lacking curative or satisfactory treatments. The company's approach is based on its proprietary Pleotherapy™ platform, which uses network pharmacology to identify and develop synergistic combinations of already-approved drugs at new, lower doses. This strategy aims to create more effective and safer treatments. Pharnext's lead product candidate, PXT3003, is an oral fixed-dose combination therapy in development for the treatment of Charcot-Marie-Tooth disease type 1A (CMT1A), a rare, debilitating inherited peripheral neuropathy.

Recent filings

Filing Released Lang Actions
Pharnext appoints Amit Kohli as Chief Operating Officer
Board/Management Information Classification · 1% confidence The document is a press release announcing a specific corporate event: the appointment of Amit Kohli as Chief Operating Officer. It uses keywords like 'DGAP-News', 'Change of Personnel', and details the executive's background and responsibilities. This clearly falls under the category of announcing changes in senior management. The corresponding code is MANG (Board/Management Information). The document length is moderate (5394 chars), indicating it is the primary announcement, not just a brief notice of publication (RPA/RNS).
2018-04-26 English
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 1% confidence The document is a press release announcing a specific corporate event: the appointment of Amit Kohli as Chief Operating Officer (COO). This type of announcement details changes in senior management personnel. According to the definitions, 'Board/Management Information' (Code: MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' The content perfectly matches this description, as it focuses entirely on a new executive hire.
2018-04-26 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 1% confidence The document is titled "Communiqué de Presse" (Press Release) and announces a significant personnel change: the appointment of Amit Kohli as Chief Operating Officer (Directeur des Opérations). This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of Board/Management Information (MANG). The document is short and focused solely on this executive appointment, not a comprehensive financial report or a general regulatory filing.
2018-04-26 French
Pharnext to Showcase PLEOTHERAPYTM R&D Platform at the 8th Annual Global Orphan Drug Conference
Environmental & Social Information Classification · 1% confidence The document is a short news release dated April 19, 2018, announcing that Pharnext will present its R&D platform at the 8th Annual Global Orphan Drug Conference and will also attend the AAN Annual Meeting. It contains company boilerplate information and contact details. The structure, use of DGAP-News header, and the content (announcing participation in future events/presentations) strongly suggest this is a general corporate announcement rather than a specific financial filing like a 10-K, ER, or IR. Since it is a regulatory news service dissemination (DGAP) announcing corporate activity that doesn't fit the other specific categories (like M&A, Dividend, Management Change), the most appropriate fallback category is Regulatory Filings (RNS). The document length (4648 chars) is short, but the content is an announcement of future participation, not the publication of a major report itself, so RPA is less fitting than RNS for this type of general news update distributed via a regulatory wire service.
2018-04-19 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is a press release announcing that a company executive will present at an upcoming industry conference (8th Annual Global Orphan Drug Conference) and that the company will exhibit at another meeting (AAN Annual Meeting). It also provides general company information and contact details. This type of announcement, which publicizes participation in industry events or presentations, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, etc.). It is an announcement related to investor/public relations activities, but not a formal regulatory filing or a core financial report. Given the options, the most appropriate general category for an announcement that doesn't fit elsewhere, especially one related to corporate activities and outreach, is the fallback category, Regulatory Filings (RNS), as it serves as a general announcement mechanism.
2018-04-19 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release ("Communiqué de Presse") announcing that Pharnext will present its R&D platform at the 8th annual Global Orphan Drug Conference. It details the date, time, title of the presentation, and location. It also mentions the company's pipeline (PXT3003, PXT864) and its PLEOTHERAPY™ approach. This type of announcement, focusing on participation in an external industry conference or event where company information will be shared, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is an announcement related to investor/industry engagement, but not a formal regulatory filing, earnings release, or management change. Given the options, the most appropriate general category for miscellaneous corporate announcements that don't fit elsewhere is 'Regulatory Filings' (RNS), as it serves as a fallback for non-standard corporate communications, although 'Investor Presentation' (IP) might seem close, this is an announcement *about* a presentation, not the presentation itself. However, since it is a general corporate announcement about an upcoming event, RNS is the best fit among the provided codes for non-standard news releases.
2018-04-19 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.